Skip to main content
. 2020 Nov 20;21(22):8807. doi: 10.3390/ijms21228807

Table 1.

Molecular assays and main characteristics of the studies for advanced breast cancer with ESR1 mutations.

First Author [Year] Tumor Type (n) Sample Type Detection Method Sequencing Equipment of Kit (Company) Most Frequent ESR1 Study Country
NGS based
Bartels et al., (2018), [78] BC with bone metastases (231) FFPE NGS and ddPCR Ion PGM Hi-Q Kit v2 using 318 v2 Chips and QuantStudio 3D Digital PCR System (Thermo Fisher Scientific, Germany) D538G Germany
Cancer Genome Atlas, (2012), [16] Luminal BC (169) Tissue NGS and several methods Illumina (Illumina, USA) NA Multi-national
Ellis et al., (2012), [17] Luminal BC (46) Snap-frozen tissue NGS Illumina (Illumina, USA) NA USA
Jeselsohn et al., (2014), [40] Metastatic BC (76) FFPE NGS HiSeq2000 (Illumina, USA) D538G and Y537N USA and Spain
Lefebvre et al., (2016), [29] Metastatic BC (143) Fresh frozen tumor biopsy NGS Illumina HiSeq2500, HiSeq4000, or NextSeq500 (Illumina, USA) NA France
Merenbakh-Lamin et al., (2013), [55] Metastatic BC (13) FFPE NGS Illumina HiSeq2000 (Illumina, USA) D538G Israel
Nik-Zainal et al., (2016) [83] BC (560) FFPE NGS Illumina GAIIx, Hiseq 2000 or Hiseq 2500 (Illumina, USA) NA Multi-national
Niu et al., (2015) [36] Metastatic BC (222) FFPE NGS Illumina HiSeq2000 platform (Illumina, USA) Codon Y537 USA
Robinson et al., (2013) [33] Metastatic BC (11) Frozen needle biopsy NGS Illumina HiSeq2000 platform (Illumina, USA) NA USA
Toy et al., (2013) [34] Advanced BC and Metastatic BC (36) Fresh frozen tissue and FFPE NGS Illumina Hiseq 2000 (Illumina, USA) D538G USA
Toy et al., (2017) [87] Metastatic BC (265) FFPE NGS Illumina HiSeq 2500 (Illumina, USA) D538G USA
Yanagawa et al., (2017) [89] Primary BC (16) and recurrent BC (46) FFPE and plasma NGS Torrent PGM instrument (Thermo Fisher Scientific, USA) D538G Japan
ddPCR based
Chandarlapaty et al., (2016) [79] Metastatic BC (541) related to BOLERO-2 clinical trial Plasma in EDTA Single ddPCR QX200 Droplet Digital PCR System (Bio-Rad Laboratories, USA) D538G USA
Chu et al., (2016) [80] Metastatic BC (23) Plasma in Streck BCT DNA tube or EDTA ddPCR QX200 Droplet Digital PCR System (Bio-Rad Laboratories, USA) D538G USA
Clatot et al., (2016) [81] BC with progression (144) Plasma in heparinized tube Single ddPCR QX200 Droplet Digital PCR System (Bio-Rad Laboratories, USA) D538G France
Gyanchandani et al., (2017) [90] Relapsed or metastatic BC (16) Plasma in Streck Cell-free DNA blood tubes ddPCR QX100 Droplet Digital PCR System (Bio-Rad Laboratories, USA) D538G USA
Fribbens et al., (2016) [82] BC with relapse or progression (161) related to SoFEA and PALOMA-3 clinical trials Plasma in EDTA Multiplex and uniplex ddPCR QX200 Droplet Digital PCR System (Bio-Rad Laboratories, USA) D538G USA
Schiavon et al., (2015] [84] Advanced BC (171) Plasma in EDTA or Streck Cell-Free DNA BCT tube, and FFPE Multiplex ddPCR QX200 Droplet Digital PCR System (Bio-Rad, USA), Ion AmpliSeq Breast Cancer Panel (Thermo Fisher Scientific, USA), and PI chip using the Ion PI OT2 200 Kit (Thermo Fisher Scientific, USA) D538G United Kingdom
Sefrioui et al., (2015) [35] Metastatic BC (7) Frozen pleural biopsy, FFPE for primary tumor sample, and plasma in heparinized tube ddPCR QuantStudio 3D Digital PCR System (Thermo Fisher Scientific, USA) NA France
Spoerke et al. (2016) [85] Metastatic BC (153) related to FERGI clinical trial Plasma and FFPE ddPCR QX200 Droplet Digital PCR System (Bio-Rad Laboratories, USA) D538G USA
Takeshita et al., (2017) [86] Advanced BC (17) and Metastatic BC (69) Plasma in EDTA Single ddPCR QX200 Droplet Digital PCR System (Bio-Rad Laboratories, USA) Y537N Japan
Wang et al., (2016) [88] Primary or metastatic BC (29) Frozen tissue and plasma in Streck tubes ddPCR QX100 Droplet Digital PCR System (Bio-Rad Laboratories, USA) D538G USA

BC, breast cancer; FFPE, formalin-fixed paraffin-embedded; NGS, next-generation sequencing; ddPCR, droplet digital polymerase chain reaction.